Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LDH and melanoma.

S J Finck, A E Giuliano, D L Morton

    Cancer
    |March 1, 1983
    PubMed
    Summary

    Monitoring serum lactate dehydrogenase (LDH) is valuable for detecting melanoma recurrence. An elevated LDH level can be an early indicator of disease spread, aiding in patient follow-up.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    FOXC1: an emerging marker and therapeutic target for cancer.

    Oncogene·2017
    Same author

    FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.

    Oncogene·2016
    Same author

    Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma.

    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2014
    Same author

    Assessment of DNA methylation status in early stages of breast cancer development.

    British journal of cancer·2013
    Same author

    FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.

    Oncogene·2012
    Same author

    Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis.

    Breast (Edinburgh, Scotland)·2009

    Area of Science:

    • Oncology
    • Biochemistry

    Background:

    • Melanoma recurrence monitoring is crucial for patient outcomes.
    • Serum lactate dehydrogenase (LDH) is a potential biomarker for disease progression.

    Purpose of the Study:

    • To evaluate the utility of serum LDH monitoring in the postoperative follow-up of melanoma patients.
    • To determine the relationship between elevated LDH and liver metastases in different melanoma stages.

    Main Methods:

    • Retrospective review of 121 Stage II melanoma patients' histories.
    • Analysis of charts from 58 Stage III melanoma patients with autopsies.
    • Calculation of sensitivity and specificity for LDH as an indicator of recurrence and liver metastases.

    Main Results:

    • LDH demonstrated 72.1% sensitivity and 97.0% specificity for detecting melanoma recurrence.
    • LDH showed high sensitivity (86.5%-95.1%) for identifying liver metastases.
    • Elevated LDH was the initial sign of recurrence in 12.5% of Stage II patients.
    • Mean survival after LDH elevation was 5.9 months, irrespective of liver metastases.

    Conclusions:

    • Serum LDH monitoring provides valuable information for postoperative melanoma follow-up.
    • Elevated LDH is a significant indicator of melanoma recurrence and potential liver involvement.
    • LDH monitoring can aid in early detection and management of recurrent melanoma.

    Related Experiment Videos